Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

31. August 2022 01:00 ET | Quelle: Kinarus Therapeutic Holding AG

Kinarus Therapeutics Reports H1 2022 Financial Results and Provides Corporate Update

Interim data from Phase 2 KINETIC clinical trial of KIN001 to treat hospitalized COVID-19 patients expected in Q3 2022First patient dosed with in Phase 2 KINFAST clinical trial with ambulatory...
29. August 2022 01:00 ET | Quelle: Kinarus Therapeutic Holding AG

Kinarus Therapeutics initiates KIN001 Phase II KINFAST clinical trial in COVID-19 outpatients

KINFAST to evaluate ability of KIN001 to reduce severity and duration of symptoms in ambulatory COVID-19 patientsInterim data from ongoing Phase 2 KINETIC trial in hospitalized Covid-19 patients...
22. August 2022 01:00 ET | Quelle: Kinarus Therapeutic Holding AG

Kinarus announces the issuance of convertible notes of up to CHF 20 million to an entity managed by Yorkville

Financing to be drawn in tranchesFinancing will enable Kinarus to advance the clinical development of KIN001 Basel, Switzerland, August 22, 2022. Kinarus Therapeutics Holding AG (SIX: KNRS)...